Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Yum Brands (NY:YUM)

144.04 +0.89 (+0.62%)
Official Closing Price Updated: 7:00 PM EDT, May 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Yum Brands

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
BigCommerce (BIGC): Buy, Sell, or Hold Post Q4 Earnings?
BigCommerce has been treading water for the past six months, recording a small loss of 2.3% while holding steady at $5.20. 
Via StockStory
3 Reasons to Sell HPQ and 1 Stock to Buy Instead
HP has gotten torched over the last six months - since October 2024, its stock price has dropped 33.9% to $23.95 per share. This was partly due to its softer quarterly results and might have investors... 
Via StockStory
Restaurant Sector Q1 Volatilty From Weather, Inflation — Analyst Lowers Price Targets
Commodity trends shifted in Q1, with deflation in grains but a spike in coffee prices. Restaurant stocks lag historic EPS multiples, and investors now eye April demand and potential tariff impacts. 
Via Benzinga
Topics Economy World Trade
Exposures Interest Rates Tariff
3 Reasons to Sell GH and 1 Stock to Buy Instead
What a time it’s been for Guardant Health. In the past six months alone, the company’s stock price has increased by a massive 112%, reaching $44.11 per share. This run-up might have investors... 
Via StockStory
Topics Bankruptcy
Exposures Financial Legal
Is Yum Brands Gaining or Losing Market Support?
Via Benzinga
Marriott Vacations (VAC): Buy, Sell, or Hold Post Q4 Earnings?
Shareholders of Marriott Vacations would probably like to forget the past six months even happened. The stock dropped 33% and now trades at $53.18. This might have investors contemplating their next... 
Via StockStory
Traditional Fast Food Stocks Q4 In Review: Yum! Brands (NYSE:YUM) Vs Peers
Looking back on traditional fast food stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Yum! Brands (NYSE:YUM) and its peers. 
Via StockStory
Yum! Brands Announces Q1 2025 Earnings and Conference Call Details
From Yum! Brands, Inc.
Via Business Wire
3 Reasons to Sell CSV and 1 Stock to Buy Instead
Since April 2020, the S&P 500 has delivered a total return of 91.4%. But one standout stock has nearly doubled the market - over the past five years, Carriage Services has surged 170% to $37.31 per... 
Via StockStory
Topics Stocks
Exposures US Equities
3 Reasons to Avoid CBRE and 1 Stock to Buy Instead
CBRE currently trades at $118.95 per share and has shown little upside over the past six months, posting a small loss of 4.4%. 
Via StockStory
Topics Government
Exposures Political
3 Reasons to Avoid WW and 1 Stock to Buy Instead
The past six months haven’t been great for WeightWatchers. It just made a new 52-week low of $0.16, and shareholders have lost 88.9% of their capital. This may have investors wondering how to approach... 
Via StockStory
Topics Bankruptcy
Exposures Financial Legal
Kimball Electronics (KE): Buy, Sell, or Hold Post Q4 Earnings?
What a brutal six months it’s been for Kimball Electronics. The stock has dropped 24.9% and now trades at $13.49, rattling many shareholders. This was partly due to its softer quarterly results and may... 
Via StockStory
3 Reasons to Avoid NDSN and 1 Stock to Buy Instead
What a brutal six months it’s been for Nordson. The stock has dropped 27.9% and now trades at $185.50, rattling many shareholders. This was partly driven by its softer quarterly results and might have... 
Via StockStory
Interpublic Group (IPG): Buy, Sell, or Hold Post Q4 Earnings?
Interpublic Group has gotten torched over the last six months - since October 2024, its stock price has dropped 20.5% to $25.03 per share. This was partly driven by its softer quarterly results and may... 
Via StockStory
Estée Lauder (EL): Buy, Sell, or Hold Post Q4 Earnings?
Estée Lauder has gotten torched over the last six months - since October 2024, its stock price has dropped 41.8% to $55.23 per share. This might have investors contemplating their next move. 
Via StockStory
3 Reasons to Sell CROX and 1 Stock to Buy Instead
Crocs has gotten torched over the last six months - since October 2024, its stock price has dropped 29.2% to $96.76 per share. This may have investors wondering how to approach the situation. 
Via StockStory
Xponential Fitness (XPOF): Buy, Sell, or Hold Post Q4 Earnings?
Xponential Fitness has gotten torched over the last six months - since October 2024, its stock price has dropped 39.6% to $7.43 per share. This was partly due to its softer quarterly results and might... 
Via StockStory
Exposures COVID-19
ON24 (ONTF): Buy, Sell, or Hold Post Q4 Earnings?
ON24 trades at $4.99 per share and has moved almost in lockstep with the market over the last six months. The stock has lost 17.9% while the S&P 500 is down 13.5%. This was partly due to its softer... 
Via StockStory
Topics Stocks
Exposures US Equities
Bel Fuse (BELFA): Buy, Sell, or Hold Post Q4 Earnings?
Bel Fuse’s stock price has taken a beating over the past six months, shedding 54.9% of its value and falling to a new 52-week low of $46 per share. This might have investors contemplating their next... 
Via StockStory
Topics Supply Chain
Exposures Supply Chain
Commercial Vehicle Group (CVGI): Buy, Sell, or Hold Post Q4 Earnings?
What a brutal six months it’s been for Commercial Vehicle Group. The stock has dropped 68.8% and now trades at $0.95, rattling many shareholders. This might have investors contemplating their next... 
Via StockStory
Topics Bankruptcy
Exposures Financial Legal
Omnicell (OMCL): Buy, Sell, or Hold Post Q4 Earnings?
What a brutal six months it’s been for Omnicell. The stock has dropped 24.6% and now trades at $32.45, rattling many shareholders. This was partly driven by its softer quarterly results and may have... 
Via StockStory
3 Reasons MED is Risky and 1 Stock to Buy Instead
What a brutal six months it’s been for Medifast. The stock has dropped 29.3% and now trades at $13.05, rattling many shareholders. This was partly driven by its softer quarterly results and may have... 
Via StockStory
3 Reasons to Sell ROKU and 1 Stock to Buy Instead
Shareholders of Roku would probably like to forget the past six months even happened. The stock dropped 25.4% and now trades at $58.60. This may have investors wondering how to approach the situation. 
Via StockStory
3 Reasons to Sell OSK and 1 Stock to Buy Instead
Although the S&P 500 is down 10.6% over the past six months, Oshkosh’s stock price has fallen further to $84.35, losing shareholders 15.8% of their capital. This might have investors contemplating... 
Via StockStory
Topics Stocks
Exposures US Equities
3 Reasons to Avoid JJSF and 1 Stock to Buy Instead
What a brutal six months it’s been for J&J Snack Foods. The stock has dropped 20.8% and now trades at $133, rattling many shareholders. This was partly driven by its softer quarterly results and might... 
Via StockStory
MarineMax (HZO): Buy, Sell, or Hold Post Q4 Earnings?
MarineMax has gotten torched over the last six months - since October 2024, its stock price has dropped 40.9% to a new 52-week low of $17.84 per share. This might have investors contemplating their... 
Via StockStory
Topics Bankruptcy
Exposures Financial Legal
3 Reasons POST is Risky and 1 Stock to Buy Instead
Post has been treading water for the past six months, recording a small return of 2.7% while holding steady at $117.55. However, the stock is beating the S&P 500’s 7% decline during that period. 
Via StockStory
Topics Stocks
Exposures US Equities
3 Reasons to Avoid UTI and 1 Stock to Buy Instead
Universal Technical Institute has been on fire lately. In the past six months alone, the company’s stock price has rocketed 67.9%, reaching $25.88 per share. This was partly due to its solid quarterly... 
Via StockStory
Topics Energy
Exposures Fossil Fuels
3 Reasons to Avoid MMSI and 1 Stock to Buy Instead
Since April 2020, the S&P 500 has delivered a total return of 121%. But one standout stock has doubled the market - over the past five years, Merit Medical Systems has surged 247% to $105.49 per share.... 
Via StockStory
Topics Stocks Supply Chain
Exposures Supply Chain US Equities
3 Reasons to Avoid RHI and 1 Stock to Buy Instead
Over the past six months, Robert Half’s shares (currently trading at $55.99) have posted a disappointing 15.8% loss while the S&P 500 was down 3.3%. This was partly due to its softer quarterly results... 
Via StockStory
Topics Stocks
Exposures US Equities
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.